Celebrating the “State of Possible” – CCC to Attend MassBio’s Annual Conference

,

MassBio-2019

What lies ahead for the biotechnology industry?

That question – and many more – will be discussed next week at MassBio’s Annual Conference in Cambridge, MA.

As new members of the Massachusetts Biotechnology Council, the CCC team is excited to join this year’s event entitled “The State of Possible.”

CCC’s membership in MassBio gives us the opportunity to further participate in the growth of the life science ecosystem. We look forward to sharing our expertise in creating copyright compliance and content workflow solutions for organizations within this network of innovative companies.

About MassBio’s Annual Event

This year’s keynote speaker Jeremy Levin, Chairman & CEO of Ovid Therapeutics, will kick off the program with “The State of the State of Possible: Where Are We in the History of Biotech and What Lies Ahead.” Additional topics throughout the two-day event range from leveraging artificial intelligence for drug discovery, to addressing the nation’s opioid crisis.

Meet the CCC Team

We’ll be exhibiting throughout the conference, and we’re excited to share the ways emerging life sciences organizations are using RightFind to accelerate the research process.

If you’re not attending the conference, follow all the action using hashtag #StateofPossible19 and connect with Mass Bio (@MassBio) and CCC (@copyrightclear) on Twitter for up-to-the-minute dispatches from the conference.

 

Related Reading:

Lauren Tulloch

Author: Lauren Tulloch

Lauren Tulloch is CCC’s senior director of corporate products and services. In that role, she oversees the product management team responsible for the RightFind software suite and the annual copyright licenses. Prior to joining CCC, Lauren served as a group publisher at a healthcare education & training company. She began her career as a newspaper reporter and editor.

Don't Miss a Post

Subscribe by Email

For inquiries related to this blog, email blog@copyright.com or join the conversation on social media with @copyrightclear.